HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Carter Snead Selected Research

Vigabatrin

11/2020Retinal defect in children with infantile spasms of varying etiologies: An observational study.
8/2015Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
4/2015Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
12/2014Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
7/2010Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms.
8/2007Contrast sensitivity is reduced in children with infantile spasms.
2/2005Reduced visual function associated with infantile spasms in children on vigabatrin therapy.
7/2002Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).
1/2002Treatment of infantile spasms: an evidence-based approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Carter Snead Research Topics

Disease

38Seizures (Absence Seizure)
01/2020 - 09/2001
29Epilepsy (Aura)
01/2022 - 06/2002
21Drug Resistant Epilepsy
10/2022 - 08/2003
14succinic semialdehyde dehydrogenase deficiency
03/2009 - 07/2002
12Infantile Spasms (West Syndrome)
11/2020 - 01/2002
8Partial Epilepsies (Epilepsy, Partial)
10/2022 - 05/2003
7Tuberous Sclerosis (Bourneville's Disease)
11/2016 - 01/2002
6Spasm (Spasms)
01/2018 - 02/2007
3Lennox Gastaut Syndrome
01/2015 - 08/2003
3Absence Epilepsy (Childhood Absence Epilepsy)
08/2012 - 11/2004
3Cognitive Dysfunction
11/2009 - 07/2006
3Status Epilepticus (Complex Partial Status Epilepticus)
04/2007 - 01/2006
3Alcoholism (Alcohol Abuse)
03/2006 - 01/2003
3Malformations of Cortical Development
11/2004 - 05/2002
2Brain Diseases (Brain Disorder)
01/2019 - 05/2015
2Ataxia (Dyssynergia)
03/2009 - 04/2008
2Hyperkinesis
12/2006 - 10/2003
2Narcolepsy
03/2006 - 01/2004
1Infantile Epileptic-Dyskinetic Encephalopathy
01/2019
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
09/2018
1Memory Disorders (Memory Loss)
01/2018
1Rett Syndrome (Rett's Disorder)
01/2018
1Neurodevelopmental Disorders
01/2018
1Pyridoxine-dependent epilepsy
05/2015
1Methylenetetrahydrofolate reductase deficiency
05/2015
1Menkes Kinky Hair Syndrome (Menkes Disease)
05/2015
1Pyruvate Dehydrogenase Complex Deficiency Disease
05/2015
1Nonketotic Hyperglycinemia
05/2015
1Bipolar Disorder (Manic Depressive Psychosis)
11/2011
1Mania (Manias)
11/2011
1Hydrocephalus (Hydrocephaly)
12/2010

Drug/Important Bio-Agent (IBA)

14gamma-Aminobutyric Acid (GABA)IBA
07/2015 - 01/2003
13Succinate-Semialdehyde Dehydrogenase (Succinic Semialdehyde Dehydrogenase)IBA
03/2009 - 07/2002
9VigabatrinFDA Link
11/2020 - 01/2002
9Anticonvulsants (Antiepileptic Drugs)IBA
07/2013 - 01/2002
9trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA
08/2012 - 01/2002
6Pharmaceutical PreparationsIBA
01/2020 - 01/2003
6trans-sodium crocetinate (crocetin)IBA
11/2016 - 09/2005
6CholesterolIBA
08/2012 - 01/2002
5GABA-B ReceptorsIBA
07/2015 - 07/2002
3Ethosuximide (Zarontin)FDA LinkGeneric
01/2020 - 11/2004
34-hydroxybutyric acidIBA
01/2020 - 05/2006
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2019 - 10/2003
3Adrenocorticotropic Hormone (ACTH)FDA Link
08/2015 - 01/2002
3Adrenal Cortex Hormones (Corticosteroids)IBA
04/2015 - 01/2002
34-Butyrolactone (gamma Butyrolactone)IBA
05/2009 - 03/2006
3SteroidsIBA
01/2006 - 01/2002
2Retinaldehyde (Retinal)IBA
11/2020 - 12/2014
2ProdrugsIBA
01/2020 - 03/2006
2Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2019
2Dopamine (Intropin)FDA LinkGeneric
01/2019 - 10/2003
2Valproic Acid (Depakote)FDA LinkGeneric
11/2011 - 11/2004
2Proteins (Proteins, Gene)FDA Link
11/2011 - 04/2009
2BaclofenFDA LinkGeneric
05/2009 - 01/2008
2Pentylenetetrazole (Metrazol)IBA
01/2008 - 08/2003
2Serotonin (5 Hydroxytryptamine)IBA
02/2006 - 10/2003
2SterolsIBA
11/2004 - 01/2002
2Hormones (Hormone)IBA
03/2004 - 01/2002
2BenzodiazepinesIBA
01/2002 - 09/2001
1neuroligin 2IBA
01/2020
1NeuroliginsIBA
01/2020
1Cell Adhesion MoleculesIBA
01/2020
1Medical MarijuanaIBA
11/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1Qa-SNARE Proteins (Syntaxin)IBA
01/2019
1OilsIBA
09/2018
1Plant ExtractsIBA
09/2018
1Dronabinol (THC)FDA LinkGeneric
09/2018
1p21-Activated KinasesIBA
01/2018
1Methyl-CpG-Binding Protein 2IBA
01/2018
1tertiapinIBA
10/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2015
1GABA-B Receptor AgonistsIBA
07/2015
1Aminobutyrates (Aminobutyric Acid)IBA
07/2015
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
05/2015
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
05/2015
1Oxidoreductases (Dehydrogenase)IBA
05/2015
1Prednisolone (Predate)FDA LinkGeneric
04/2015
1N'-geranylpiperazinylfarnesyl acetamideIBA
01/2015
1Drug CombinationsIBA
07/2013
1Indicators and Reagents (Reagents)IBA
05/2013
1Deoxyglucose (2 Deoxy D glucose)IBA
04/2013
1rostafuroxinIBA
11/2011
1LithiumIBA
11/2011
1Adenosine Triphosphatases (ATPase)IBA
11/2011
1Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA
11/2011
1Amobarbital (Amsal)IBA
06/2009
1GABA Receptors (GABA Receptor)IBA
04/2009

Therapy/Procedure

11Electrodes (Electrode)
10/2022 - 05/2002
6Therapeutics
01/2022 - 02/2005
5Hemispherectomy
08/2017 - 12/2010
4Ketogenic Diet
10/2014 - 08/2003
3Implanted Electrodes
10/2022 - 11/2013
3Vagus Nerve Stimulation
01/2021 - 11/2019
3Neurosurgical Procedures
12/2011 - 12/2006
2Long-Term Care
01/2020 - 01/2012
2Operative Surgical Procedures
12/2010 - 05/2003
1Anesthesia
01/2019
1Time-to-Treatment
01/2015
1Occupational Therapy (Therapy, Occupational)
08/2012